Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 10 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,038 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,038 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 16,556 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,556 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 23,005 | $101.55 | $2,336,231.37 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · nonDerivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,297.6115 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.35 to $101.80, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 5,518 | $15.91 | $87,798.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,302.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 5,518 | $10.92 | $60,238.90 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,784.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 16,554 | $6.48 | $107,223.57 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,266.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 27,594 | $5.98 | $165,070.07 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,712.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:52 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantStock Appreciation Right · Derivative | 13,730 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007235 · doc4.xml · derivative · entry 4 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,730 Underlying: Common Stock · 13,730 shares Expires 2028-01-31 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantStock Appreciation Right · Derivative | 13,730 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · derivative · entry 6 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,730 Underlying: Common Stock · 13,730 shares Expires 2028-01-31 F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 5,125 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · derivative · entry 5 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,125 Underlying: Common Stock · 5,125 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 5,500 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · derivative · entry 4 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 8,135 | $101.16 | $822,936.60 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · nonDerivative · entry 3 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,909.8654 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 5,125 | $69.58 | $356,597.50 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,044.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 5,500 | $68.96 | $379,280.00 |
DisclosureSEC source: 0001209191-18-007234 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,919.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantStock Appreciation Right · Derivative | 32,020 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 16 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,020 Underlying: Common Stock · 32,020 shares Expires 2028-01-31 F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,515 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 15 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,515 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,515 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 14 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,515 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 27,030 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 13 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,030 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,515 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 12 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,515 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 27,030 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · derivative · entry 11 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,030 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 66,845 | $101.05 | $6,754,399.82 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · nonDerivative · entry 5 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,486 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.20, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 13,515 | $15.91 | $215,039.87 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · nonDerivative · entry 4 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 13,515 | $10.92 | $147,540.55 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · nonDerivative · entry 3 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 40,545 | $6.48 | $262,618.07 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:50 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 27,030 | $5.98 | $161,696.16 |
DisclosureSEC source: 0001209191-18-007233 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:49 UTC |
MICHELSON MICHAEL WDirector
|
GrantCommon Stock | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007232 · doc4.xml · nonDerivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473 F1 · kind: Represents common stock underlying 473 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
GrantStock Appreciation Right · Derivative | 251,570 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 7 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,570 Underlying: Common Stock · 251,570 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
GrantStock Appreciation Right · Derivative | 109,780 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · derivative · entry 13 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,780 Underlying: Common Stock · 109,780 shares Expires 2028-01-31 F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 253,352 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · derivative · entry 12 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 253,352 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009 F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 84,450 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · derivative · entry 11 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,450 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 84,464 | $0.00 Strike: $13.21 | $0.00 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · derivative · entry 10 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,464 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
SaleCommon Stock | 56,000 | $100.47 | $5,626,185.60 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · nonDerivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,600 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.24 to $100.67, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Tax withholdingCommon Stock | 188,219 | $101.16 | $19,040,234.04 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,600 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionCommon Stock | 253,352 | $22.64 | $5,736,269.31 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionCommon Stock | 84,450 | $17.65 | $1,490,297.60 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:40 UTC |
HAZEN SAMUEL NPresident & COO
|
Exercise / conversionCommon Stock | 84,464 | $13.21 | $1,115,558.28 |
DisclosureSEC source: 0001209191-18-007226 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC |
Hall Charles JGroup President
|
GrantStock Appreciation Right · Derivative | 36,600 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,600 Underlying: Common Stock · 36,600 shares Expires 2028-01-31 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC |
Foster Jon MGroup President
|
GrantStock Appreciation Right · Derivative | 36,600 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007224 · doc4.xml · derivative · entry 5 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,600 Underlying: Common Stock · 36,600 shares Expires 2028-01-31 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 60,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007224 · doc4.xml · derivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 60,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 30,407 | $101.16 | $3,075,972.12 |
DisclosureSEC source: 0001209191-18-007224 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,239 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 60,000 | $22.95 | $1,377,000.00 |
DisclosureSEC source: 0001209191-18-007224 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:37 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantStock Appreciation Right · Derivative | 18,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007223 · doc4.xml · derivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
GrantStock Appreciation Right · Derivative | 18,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 15 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2028-01-31 F9 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 5,125 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 14 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,125 Underlying: Common Stock · 5,125 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 2,750 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 13 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 2,750 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 1,750 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 12 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 1,400 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 11 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,400 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal year 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 1,700 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 10 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,700 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 2,125 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 9 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,125 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.